Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)

TRPMA News

Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”

Taiwan: TRPMA and DTCO Jointly Announce the Development of “TRPMA Biopharma Trusted Platform”

(Source: TRPMA 2016-05-10）

Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA) announced the collaboration with Digital Treasury Corporation (DTCO) to jointly develop the “TRPMA Biopharma Trusted Platform”, an application of the latest Blockchain Technology.

Read More

Welcome to TRPMA website

Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), composed of 28 Taiwanese innovative biopharmaceutical companies, plays a pivotal role in coordinating the resources, strengthening alliances among the industry, the academic and the government in Taiwan. TRPMA members aim to create a competitive value chain of biopharmaceutical industry to boost the nation's economy and promote the Asian and global cooperation in biopharmaceutical innovation.

Industry News

PMRs: Researchers suggest changes to shorten postmarketing requirement timelines

A new study from researchers at Yale and Dartmouth published in the Journal of General Internal Medicine finds that drugmakers often take much longer to complete US Food and Drug Administration (FDA) mandated postmarketing requirements (PMRs) than expected based on completion timelines listed on ClinicalTrials.gov.

Read More
US: FDA drafts guidance on biomarker qualification

The US Food and Drug Administration (FDA) on Tuesday released draft guidance for industry discussing the recommended components of a biomarker development program, including how to determine the type and level of evidence sufficient to support qualification, and how these components interrelate to inform an evidentiary framework.

Read More
R&D: Scientists develop revolutionary tech to improve prostate cancer detection

A ‘revolutionary’ new medical software able to pinpoint the area from which surgeons should take a biopsy to detect prostate cancer has been developed by NIHR supported researchers.

Read More